22 December 2022

Safety alerts regarding pharmaceutical products and medical devices

Reference: CIR-2022-00000250

To all Health facilities / all health care practitioners in Dubai's private health sector

Referring to the above subject, DHA notifies all health facilities regarding the circular issued by the MOHAP for perusal and adhere to what is stated

 

 

Voluntary Recall of 3 Lots of pharmaceutical product Prenate Tabgel

Lifting the Suspension on the Registration &Marketing of the Medicinal Product Clarex (Clarithromycin) 500mg Tablet

 

 

Thanks in advance for your good co-operation

 

Drug Control Section

Health Regulation Sector

DHA

Supporting Documents:

Prenate Tabgel - سحب ثلاث تشغيلات من المستحضر الطبي ---.pdf:

View Document

رفع التعليق عن تسجيل وتسويق المنتج الطبي - Clarex (Clarithromycin) 500mg Tablet ---.pdf:

View Document